US EditionTrial Evaluating Blood Test for 10 Cancers Reaches Major Milestone
UNITED KINGDOM, JUL 30 – The Southampton-led Enlighten trial tests a blood protein screening that has shown high accuracy detecting 10 early-stage cancers in 450 patients so far.
- A PRNewswire release noted the MODERNISED study in Southampton, England reported over 450 participants have joined to evaluate ENLIGHTEN's potential to detect ten cancers early.
- Given current UK screening programmes, only four focus on single cancers, while around 385,000 new UK cancer diagnoses occur annually.
- Professor Davies said that ENLIGHTEN measures coloured light signatures from proteins that can change even when cancers are too small to shed detectable DNA.
- Early detection offers the benefit that `Detecting cancer early means that treatment can begin sooner, increasing the chances of successful outcomes for patients`, says Dr Victoria Goss, emphasizing the importance of timely diagnosis.
- Led by the Southampton Clinical Trials Unit, recruitment continues to 1,000 patients and 350 volunteers for early cancer detection study.
Insights by Ground AI
Does this summary seem wrong?
45 Articles
45 Articles
Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone
·Chicago, United States
Read Full ArticleCoverage Details
Total News Sources45
Leaning Left6Leaning Right5Center15Last UpdatedBias Distribution58% Center
Bias Distribution
- 58% of the sources are Center
58% Center
L 23%
C 58%
R 19%
Factuality
To view factuality data please Upgrade to Premium
